CLINICAL_TRIALS
trial_result
· 2015-08-13
Clinical Trial Update: A Study to Evaluate the Effect of Bexarotene on Beta-Amyloid and Apolipoprotein E Metabolism in Healthy Subjects [Phase 1]
Summary
A completed Phase 1 study evaluated the effect of bexarotene on beta-amyloid and apolipoprotein E metabolism in healthy subjects.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ReXceptor, Inc. | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED